ENVB
Price
$3.90
Change
-$0.40 (-9.30%)
Updated
Jan 30, 04:59 PM (EDT)
Capitalization
2.98M
55 days until earnings call
SLNCF
Price
$1.90
Change
+$0.89 (+88.12%)
Updated
Jan 27 closing price
Capitalization
269.12M
Ad is loading...

ENVB vs SLNCF

Header iconENVB vs SLNCF Comparison
Open Charts ENVB vs SLNCFBanner chart's image
Enveric Biosciences
Price$3.90
Change-$0.40 (-9.30%)
Volume$1.24K
Capitalization2.98M
Silence Therapeutics
Price$1.90
Change+$0.89 (+88.12%)
Volume$1.23K
Capitalization269.12M
ENVB vs SLNCF Comparison Chart
Loading...
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ENVB vs. SLNCF commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ENVB is a StrongBuy and SLNCF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 31, 2025
Stock price -- (ENVB: $3.90 vs. SLNCF: $1.90)
Brand notoriety: ENVB and SLNCF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ENVB: 1511% vs. SLNCF: 94%
Market capitalization -- ENVB: $2.98M vs. SLNCF: $269.12M
ENVB [@Biotechnology] is valued at $2.98M. SLNCF’s [@Biotechnology] market capitalization is $269.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $379.55B to $0. The average market capitalization across the [@Biotechnology] industry is $2.47B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ENVB’s FA Score shows that 1 FA rating(s) are green whileSLNCF’s FA Score has 0 green FA rating(s).

  • ENVB’s FA Score: 1 green, 4 red.
  • SLNCF’s FA Score: 0 green, 5 red.
According to our system of comparison, SLNCF is a better buy in the long-term than ENVB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ENVB’s TA Score shows that 3 TA indicator(s) are bullish while SLNCF’s TA Score has 2 bullish TA indicator(s).

  • ENVB’s TA Score: 3 bullish, 6 bearish.
  • SLNCF’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, SLNCF is a better buy in the short-term than ENVB.

Price Growth

ENVB (@Biotechnology) experienced а -21.92% price change this week, while SLNCF (@Biotechnology) price change was +26.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.11%. For the same industry, the average monthly price growth was +1.05%, and the average quarterly price growth was +4.49%.

Reported Earning Dates

ENVB is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-1.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLNCF($269M) has a higher market cap than ENVB($2.98M). ENVB (-27.455) and SLNCF (-27.619) have similar YTD gains . ENVB has higher annual earnings (EBITDA): -10.35M vs. SLNCF (-56.89M). SLNCF has more cash in the bank: 129M vs. ENVB (3.11M). ENVB has less debt than SLNCF: ENVB (0) vs SLNCF (139K). SLNCF has higher revenues than ENVB: SLNCF (16.2M) vs ENVB (0).
ENVBSLNCFENVB / SLNCF
Capitalization2.98M269M1%
EBITDA-10.35M-56.89M18%
Gain YTD-27.455-27.61999%
P/E RatioN/AN/A-
Revenue016.2M-
Total Cash3.11M129M2%
Total Debt0139K-
FUNDAMENTALS RATINGS
ENVB vs SLNCF: Fundamental Ratings
ENVB
SLNCF
OUTLOOK RATING
1..100
562
VALUATION
overvalued / fair valued / undervalued
1..100
15
Undervalued
37
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9365
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ENVB's Valuation (15) in the Electronics Or Appliances industry is in the same range as SLNCF (37) in the null industry. This means that ENVB’s stock grew similarly to SLNCF’s over the last 12 months.

ENVB's Profit vs Risk Rating (100) in the Electronics Or Appliances industry is in the same range as SLNCF (100) in the null industry. This means that ENVB’s stock grew similarly to SLNCF’s over the last 12 months.

SLNCF's SMR Rating (98) in the null industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that SLNCF’s stock grew similarly to ENVB’s over the last 12 months.

SLNCF's Price Growth Rating (65) in the null industry is in the same range as ENVB (93) in the Electronics Or Appliances industry. This means that SLNCF’s stock grew similarly to ENVB’s over the last 12 months.

SLNCF's P/E Growth Rating (100) in the null industry is in the same range as ENVB (100) in the Electronics Or Appliances industry. This means that SLNCF’s stock grew similarly to ENVB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ENVBSLNCF
RSI
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 24 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 24 days ago
71%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 24 days ago
64%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 24 days ago
65%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 24 days ago
63%
Advances
ODDS (%)
Bullish Trend 25 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 24 days ago
73%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLNCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRMY39.540.72
+1.85%
Harmony Biosciences Holdings
EXEL32.93-0.03
-0.09%
Exelixis
TRST31.97-0.05
-0.16%
TrustCo Bank Corp
GMGI1.90-0.04
-2.06%
Golden Matrix Group
QNRX0.29-0.02
-6.81%
Quoin Pharmaceuticals Ltd

ENVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with PRQR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
-9.30%
PRQR - ENVB
43%
Loosely correlated
+8.04%
ALNY - ENVB
36%
Loosely correlated
+1.16%
ORMP - ENVB
33%
Poorly correlated
-2.22%
SLNCF - ENVB
28%
Poorly correlated
N/A
IMNN - ENVB
28%
Poorly correlated
+1.08%
More

SLNCF and

Correlation & Price change

A.I.dvisor tells us that SLNCF and ENVB have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SLNCF and ENVB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLNCF
1D Price
Change %
SLNCF100%
N/A
ENVB - SLNCF
29%
Poorly correlated
-9.30%
RNXT - SLNCF
24%
Poorly correlated
-0.81%
QLGN - SLNCF
21%
Poorly correlated
+1.95%
SOLTF - SLNCF
9%
Poorly correlated
N/A
PVCT - SLNCF
8%
Poorly correlated
-3.17%
More